| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2010 | US7732474 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
| 06/08/2010 | US7732473 Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof |
| 06/08/2010 | US7732472 Mitotic kinesin inhibitors |
| 06/08/2010 | US7732471 e.g. 2-Methyl-6-[3-(5-methyl-2-m-tolyloxazol-4-ylmethoxy)propoxymethyl]benzoic acid; peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonists/antagonists; insulin-related metabolic disorders of the blood such as hyperlipidemia, diabetes, insulin-resistance; atherosclerosis |
| 06/08/2010 | US7732468 3-aryl-6-aryl-[ 1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 06/08/2010 | US7732467 Administering the dihydropyridine calcium channel antagonist, nilvadipine to treat a cerebral amyloidogenic disease, such as Alzheimer's disease, transmissible spongiform encephalopathy, scrapie, traumatic brain injury, cerebral amyloid angiopathy and Gerstmann-Straussler-Scheinker syndrome |
| 06/08/2010 | US7732466 5-chloro-thiophene-2-carboxylic acid-N-{1-[3-chloro-4-(pyrrolidin-1-yl-carbonyl)-phenylcarbamoly]-ethyl}-amide, having antithrombotic activity and blood-coagulation factor Xa inhibiting activity |
| 06/08/2010 | US7732465 {1-Methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)-amine; inhibitors of kinase/Raf kinase activity associated with tumorigenesis, serine/threonine kinase or receptor tyrosine kinase; cancer; tumors; inhibit MAPK signaling pathway |
| 06/08/2010 | US7732464 non-selective and selective serotonin receptor antagonists, usedfor for treating gastrointestinal disorders such as hypermotility, irritable bowel syndrome (IBS), constipation or diarrhea predominant IBS, pain and non-pain predominant IBS and bowel hypersensitivity |
| 06/08/2010 | US7732463 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders |
| 06/08/2010 | US7732462 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 06/08/2010 | US7732461 Tryclic nitrogen containing compounds and their use as antibacterials |
| 06/08/2010 | US7732460 Heterocyclic compounds, their preparation and their use as antibacterials |
| 06/08/2010 | US7732459 CCR1 antagonists and methods of use therefor |
| 06/08/2010 | US7732458 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them |
| 06/08/2010 | US7732457 enzyme inhibitors such as 6-{2-(2-Chloro-phenyl)-5-[4-(pyrimidin-2-yloxy)-phenyl]pyrrol-1-ylmethyl}-pyridin-2-ylamine, used to treat beta-amyloid deposits and neurofibrillary tangles; Alzheimer's disease |
| 06/08/2010 | US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 06/08/2010 | US7732455 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine |
| 06/08/2010 | US7732454 Inhibitors of Bruton's tyrosine kinase |
| 06/08/2010 | US7732453 e.g. N-[2-(6-{[(3,4-dichlorophenyl)methyl]amino}-2-(4-methoxyphenyl)-3-oxo-4-hydropyridino[2,3-b]pyrazin-4-yl)ethyl]acetamide; antidiabetic agent; abnormal lipid levels, cardiovascular disease, obesity, oily skin conditions, metabolic syndrome |
| 06/08/2010 | US7732452 Thiophene derivatives which are HM74A agonists |
| 06/08/2010 | US7732451 Naphthalene-containing melanocortin receptor-specific small molecule |
| 06/08/2010 | US7732450 Antifungal ketoconazole composition for topical use |
| 06/08/2010 | US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis |
| 06/08/2010 | US7732448 pesticides such as 4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine, having an excellent ability to control pests |
| 06/08/2010 | US7732447 such as 4-Pyridin-3-yl-2,5-dihydro-pyridazino[4,5-b]indol-1-one, used as inhibitors of vascular endothelial growth factor receptor (VEGFR) kinase, mixed lineage kinase (MLK) or cyclin-dependent kinase (CDK); treatment of angiogenic disorders and neurodegenerative diseases |
| 06/08/2010 | US7732446 such as (1-Aminomethyl-6,8-dimethoxy-isoquinolin-4-yl)-(3,4-dihydro-1H-isoquinolin-2-yl)-methanone, that have advantageous potency, stability, selectivity, toxicity and/or pharmacokinetic properties |
| 06/08/2010 | US7732445 Pyridazinyl compounds such as 11-(6-imino-3-phenylpyridazin-1(6H)-yl)-N-(2-(1-methylpyrrolidin-2-yl)ethyl)-undecanamide, use for the treatment of tissue barrier dysfunction, tumor metastasis and related disease states |
| 06/08/2010 | US7732444 4-{2-[4-(3-{[(3-Amino-propyl)-ethyl-amino]-methyl}-phenyl)-pyrimidin-2-ylamino]-ethyl}-phenol, used as protein kinase C inhibitors |
| 06/08/2010 | US7732443 Prostaglandin derivatives useful in treating vision defects, inflammatory bowel disease and alopecia |
| 06/08/2010 | US7732442 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases |
| 06/08/2010 | US7732441 Azabicycloalkane compounds |
| 06/08/2010 | US7732440 Phenothiazin derivatives, method for the production thereof and use thereof as pharmaceuticals |
| 06/08/2010 | US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 06/08/2010 | US7732438 CGRP receptor antagonists |
| 06/08/2010 | US7732437 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one |
| 06/08/2010 | US7732435 vanilloid receptor antagonists such as 7-(4-Chlorophenyl)-6-isopropyl-3-methyl-2,3-dihydro-1H-1-aza-4,5-dioxa-phenanthren-8-one, used for treating nociceptive pain; analgesics |
| 06/08/2010 | US7732434 9-Amino-14,30-dichloro-5-methyl-4,24-dioxa-3,8,10,16,19-pentaazatetracyclo-[23.2.2.212,15.02,6 ]hentriaconta-1(27),2,5,8,12,14,21,25,28,30-decaene-7,17-dione; inhibit the processing of amyloid precursor protein; Alzheimer's Disease (AD) and Down's Syndrome |
| 06/08/2010 | US7732433 Biologically active complex |
| 06/08/2010 | US7732432 such as (11 beta ,16 beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl ethylcarbamate, having potent antiinflammatory and immunosuppressive activity and possess advantages over steroidal glucocorticoid ligands with respect to side effects, efficacy, toxicity and/or metabolism |
| 06/08/2010 | US7732431 for inducing contraception; for treating menopause; thermoformed packages |
| 06/08/2010 | US7732430 suppressing follicle maturation and ovulation and replacing the endogenous ovarian secretion of 17 beta-estradiol; 1,3,5 (10)-estratrien-3, 15 alpha ,16 alpha ,17 beta -tetrol for example; does not employ co-administration of a luteinizing hormone releasing hormone; less side effects |
| 06/08/2010 | US7732429 Reducing tetracycline resistance in living cells |
| 06/08/2010 | US7732428 Surgical compositions and methods of using the same |
| 06/08/2010 | US7732427 Multifunctional and biologically active matrices from multicomponent polymeric solutions |
| 06/08/2010 | US7732426 Isocyclomaltooligosaccharide (S) , isocyclomaltooligosaccharide-forming enzyme, their preparation and uses |
| 06/08/2010 | US7732425 Comprises trehalose; for treatment of Gougerot-Sjogren Syndrome |
| 06/08/2010 | US7732424 Purine derivatives and methods of use thereof |
| 06/08/2010 | US7732422 TRPM-2 antisense therapy |
| 06/08/2010 | US7732421 RNAI-mediated inhibition of tumor necrosis factor α-related conditions |
| 06/08/2010 | US7732420 Combinations of transfection lipids exhibiting increased transfection efficiencies |
| 06/08/2010 | US7732417 Methods and compositions for RNA interference using recombinant Dicer and Argonaut |
| 06/08/2010 | US7732416 For protecting plants against parasitic feeding pests; also against the infestation of pets, especially cats and dogs, by fleas, ticks and nematodes; pesticides for crop protection |
| 06/08/2010 | US7732415 Topical treatment or prevention of ocular infections |
| 06/08/2010 | US7732414 cosmetic make-up removing composition; for treating aging, fibroblasts, keratinocytes; particularly hyaluronic acid, proteoglycans |
| 06/08/2010 | US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia |
| 06/08/2010 | US7732408 increases dairy cattle breeding efficiency with a reduction in the number of months in the breeding cycle without the need for detecting standing estrus of a dairy cow prior to insemination; administering progesterone; without use of heat detection prior to insemination |
| 06/08/2010 | US7732405 comprising a stabilizing benzamidine compound for control the chemical and/or physical degradation products such as enzymatic degradation or autocatalysis products; in air-tight container, antioxidant-free |
| 06/08/2010 | US7732403 Treatment of T-cell mediated diseases |
| 06/08/2010 | US7732402 Mammalian telomerase |
| 06/08/2010 | US7732400 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 06/08/2010 | US7732374 fipronil, chlorpyrifos,thiamethoxam; synergistic; phytopathogens; crops |
| 06/08/2010 | US7732207 Method for expression of small antiviral RNA molecules within a cell |
| 06/08/2010 | US7732197 Recombinant nucleic acid of a nucleotide sequence encoding an autocatalytically cleaving and trans-acting ribozymes linked to a tissue-specific or pathogen-specific promoter; anticancer or antiproliferative agents |
| 06/08/2010 | US7732193 Expressing preferential nucleotide sequences in cells; obtain cell, transfect, recover packaged retrovirus, infect target cell, monitor gene expression in cell |
| 06/08/2010 | US7732186 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 06/08/2010 | US7732161 fermentation method that converts hydroxymethylglutaryl-CoA to L-mevalonic acid and eventually to isoprenoids (farnesol and geranylgeraniol ) |
| 06/08/2010 | US7732159 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy |
| 06/08/2010 | US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor |
| 06/08/2010 | US7732144 assessing levels of expression of Thymidylate Synthase (TS) and Excision Repair Cross-Complementing (ERCC1) mRNA obtained from fixed or fixed and paraffin-embedded (FPE) tumor cells |
| 06/08/2010 | US7732062 Charge transport layers and organic electron devices comprising same |
| 06/08/2010 | US7732000 Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix |
| 06/08/2010 | US7731992 astaxanthin, black cohosh, echinacea, and phytosterols, antitumor agents for breast cancer |
| 06/08/2010 | US7731989 Gastric retained gabapentin dosage form |
| 06/08/2010 | US7731985 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints |
| 06/08/2010 | US7731983 Method and composition for the treatment of scars |
| 06/08/2010 | US7731973 Administering estriol to treat multiple sclerosis, autoimmune diseases, psoriasis, Sjogren's syndrome, encephalomyelitis; inflammatory bowel, Crohn's, Hashimoto's, or Addison's disease; diabetes, myasthenia gravis, lupus, rheumatoid arthritis, polymyositis; immunotherapy; magnetic resonance imaging |
| 06/08/2010 | US7731953 inducing proliferation of CD4+ T cells using human thymic stromal derived lymphopoietin (TSLP) polypeptide; asthma or rhino-conjunctivitis |
| 06/08/2010 | US7731951 Viruses for the treatment of cellular proliferative disorders |
| 06/08/2010 | US7731947 Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| 06/08/2010 | US7731945 Immunotherapy for reversing immune suppression |
| 06/08/2010 | US7731941 Brilliant Blue G (BBG) derivatives; alternative dye as surgical adjuvant in ophthalmic surgeries for membrane removing; vitreo-retinal disease: epiretinal membrane, diabetic retinopathy and macular edema; hypermature and congenital cataract; corneal transplantation; nontoxic, better dye ability |
| 06/08/2010 | US7731940 N-(2-[4-(2-methoxyphenyl)piperazinyl]ethyl)-N-(2-pyridyl)-N-(4-18F-fluoro-methylcyclohexane)carboxamide, used for treating panic, bipolar or seizure disorders, and as a quantitative tool for measuring serotonin concentration in the brain |
| 06/08/2010 | CA2602037C Indicator for orally administered compositions |
| 06/08/2010 | CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide |
| 06/08/2010 | CA2564030C Salt forms of [r-(r*, r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
| 06/08/2010 | CA2519272C Cephalosporin in crystalline form |
| 06/08/2010 | CA2506712C Rapidly-decomposing administrable form for releasing ingredients in the oral cavity or in bodily cavities |
| 06/08/2010 | CA2492831C Color-stable, low impurity tocopherol compositions and processes for preparing the same |
| 06/08/2010 | CA2479831C Benzofuran derivative |
| 06/08/2010 | CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents |
| 06/08/2010 | CA2467222C Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
| 06/08/2010 | CA2448278C Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception |
| 06/08/2010 | CA2447178C Pharmaceutical composition for use in hormone replacement therapy |
| 06/08/2010 | CA2444103C Composition for treating drug-induced constipation with 15-keto-prostaglandins |
| 06/08/2010 | CA2442281C Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| 06/08/2010 | CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 06/08/2010 | CA2440213C Method for improving the well-being of poultry by in-ovo injection of carnitine |
| 06/08/2010 | CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
| 06/08/2010 | CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |